Figure 3.
Biomarker expression comparison between primary and PDX tumours. (A) IHC analysis of the normal biomarker (CDH17, ki-67, ABC) expression levels in the hCC0011 and hCC018 metastatic CRC and their PDX models. (B) IHC analysis of α-SMA expression levels of the 2 cases of metastatic CRC and their PDX models. IHC, immunohistochemistry; ABC, Active β-catenin; α-SMA, α-smooth muscle actin. Scale bars, 50 μm in black.

Biomarker expression comparison between primary and PDX tumours. (A) IHC analysis of the normal biomarker (CDH17, ki-67, ABC) expression levels in the hCC0011 and hCC018 metastatic CRC and their PDX models. (B) IHC analysis of α-SMA expression levels of the 2 cases of metastatic CRC and their PDX models. IHC, immunohistochemistry; ABC, Active β-catenin; α-SMA, α-smooth muscle actin. Scale bars, 50 μm in black.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close